Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
USNA 
USANA Health Sciences Inc (USNA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: USNA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $61
1 Year Target Price $61
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -30.78% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 558.57M USD | Price to earnings Ratio 16.98 | 1Y Target Price 61 |
Price to earnings Ratio 16.98 | 1Y Target Price 61 | ||
Volume (30-day avg) 1 | Beta 0.64 | 52 Weeks Range 23.10 - 41.84 | Updated Date 09/17/2025 |
52 Weeks Range 23.10 - 41.84 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.8 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.79% | Operating Margin (TTM) 7.09% |
Management Effectiveness
Return on Assets (TTM) 5.14% | Return on Equity (TTM) 6.35% |
Valuation
Trailing PE 16.98 | Forward PE 11.92 | Enterprise Value 401957026 | Price to Sales(TTM) 0.62 |
Enterprise Value 401957026 | Price to Sales(TTM) 0.62 | ||
Enterprise Value to Revenue 0.45 | Enterprise Value to EBITDA 4.16 | Shares Outstanding 18271800 | Shares Floating 9581020 |
Shares Outstanding 18271800 | Shares Floating 9581020 | ||
Percent Insiders 42.93 | Percent Institutions 61.22 |
Upturn AI SWOT
USANA Health Sciences Inc
Company Overview
History and Background
USANA Health Sciences Inc. was founded in 1992 by Dr. Myron Wentz. Initially focused on developing and manufacturing high-quality nutritional supplements, USANA adopted a direct selling business model, emphasizing independent distributors. The company has expanded globally, facing both periods of rapid growth and challenges related to regulatory scrutiny and distributor practices.
Core Business Areas
- Nutritional Supplements: USANA's core business involves developing, manufacturing, and selling nutritional supplements, including vitamins, minerals, antioxidants, and other health-related products. These products are intended to support overall health and wellness.
- Personal Care Products: USANA also offers a line of personal care products, including skincare, haircare, and oral care items. These products complement their nutritional offerings.
Leadership and Structure
The leadership team includes the CEO (Jim Brown) and a board of directors. The company operates with a network marketing structure, relying on independent distributors to sell and promote products.
Top Products and Market Share
Key Offerings
- CellSentials: Flagship nutritional supplement providing essential vitamins, minerals, and antioxidants. Competitors include multi-vitamins from brands like Centrum (owned by Haleon), One A Day (owned by Bayer), and Nature Made (owned by Otsuka Pharmaceutical). Revenue is substantial, likely accounting for a significant percentage of total nutritional supplement sales, though precise figures are not publicly broken out by product. Market share within the broader vitamin and supplement market is estimated to be low single digits.
- Proflavanol C: A supplement combining grape seed extract and vitamin C, promoted for antioxidant benefits. Competitors include similar products from brands like Life Extension and NOW Foods. Revenue stream is significant. Market share within the antioxidant supplement market is estimated to be low single digits.
- USANA MySmartShake: Meal replacement shakes. Competitors include Herbalife and SlimFast. Revenue stream is significant. Market share within the meal replacement market is estimated to be low single digits.
Market Dynamics
Industry Overview
The nutritional supplement industry is large and highly competitive, driven by increasing consumer awareness of health and wellness. It is subject to regulatory oversight and evolving consumer preferences.
Positioning
USANA positions itself as a premium provider of science-based nutritional supplements sold through a direct selling model. Its competitive advantages include its in-house research and development capabilities and a loyal distributor network.
Total Addressable Market (TAM)
The global dietary supplements market is estimated to be worth hundreds of billions of USD and is expected to grow in the coming years. USANA's positioning allows it to capture a portion of this market by focusing on high-quality products and a direct-selling distribution model.
Upturn SWOT Analysis
Strengths
- Strong brand reputation for quality
- Direct selling model provides a dedicated sales force
- In-house research and development
- Global presence
Weaknesses
- Reliance on distributor network can lead to inconsistencies
- Susceptibility to regulatory scrutiny
- High product pricing compared to competitors
- Negative perception associated with multi-level marketing
Opportunities
- Expanding into new geographic markets
- Developing new product lines to meet changing consumer needs
- Leveraging digital marketing to reach new customers
- Partnerships with healthcare professionals
Threats
- Increasing competition from other supplement manufacturers
- Changing regulatory landscape
- Negative publicity related to direct selling practices
- Economic downturn affecting consumer spending
Competitors and Market Share
Key Competitors
- HLF
- NUTR
- GNC
Competitive Landscape
USANA competes with other direct selling companies, as well as traditional retail supplement brands. Advantages include its science-based approach and distributor network. Disadvantages include higher prices and the challenges associated with direct selling.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been influenced by market trends, product launches, and geographic expansion.
Future Projections: Future projections depend on analyst estimates, which are subject to change. Consult financial analysis websites for current analyst projections.
Recent Initiatives: Recent strategic initiatives might include new product launches, market expansion, or changes in the distribution model.
Summary
USANA is a global health and wellness company operating through a direct selling model. Its strengths lie in its product quality and distributor network, while weaknesses include reliance on distributors and negative MLM perceptions. Growth opportunities exist in new markets and product lines. The company needs to watch out for increasing competition and changing regulations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- USANA Health Sciences Inc. Investor Relations
- Financial Analysis Websites
- Industry Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share and TAM estimates are approximate and subject to change. Financial data should be verified with official company filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About USANA Health Sciences Inc
Exchange NYSE | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 1996-07-25 | CEO & President Mr. Jim Brown | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 1700 | Website https://www.usana.com |
Full time employees 1700 | Website https://www.usana.com | ||
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.